Patient informed choice between palliative chemotherapy and best supportive care.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24043

Enrollment

170

Registered

2007-11-02

Start date

2007-01-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paliative chemotherapy.

Interventions

Decision Aid lasting about 35 minutes.

Eligibility

Inclusion criteria

Inclusion criteria: Patients with distant metastases or loco-regional recurrence after primary breast, colon, or ovarian cancer are eligible, if they are treated or have been treated with first line palliative chemotherapy.

Exclusion criteria

Exclusion criteria: Exclusion criteria are labile personality structure, as assessed by the physicians, and a Karnofsky lower than 60.

Design outcomes

Primary

Measure	Time frame
Risk information acceptance.	—

Secondary

Measure	Time frame
Physician's judgment of patients' information acceptance Well-being, Knowledge, Autonomy.	—

Contacts

Public ContactP.F.M. Stalmeier

University Medical Center St. Radboud, Department of Radiotherapy, Geert Grooteplein 14A Room 0.10

p.stalmeier@mta.umcn.nl+31 (0)24 3610592

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)